OFCCR CLINICAL DIAGNOSIS AND TREATMENT FORM

Similar documents
Gastric Cancer Histopathology Reporting Proforma

IMAGING GUIDELINES - COLORECTAL CANCER

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

COLORECTAL CANCER FAISALGHANISIDDIQUI MBBS; FCPS; PGDIP-BIOETHICS; MCPS-HPE

Obtaining the diagnosis:

COLON AND RECTAL CANCER

COLON AND RECTAL CANCER

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

COLORECTAL CARCINOMA

By: Tania Cortas, MD Arizona Oncology 03/10/2015

LOINC. Clinical information. RCPA code. Record if different to report header Operating surgeon name and contact details. Absent.

COLON CANCER CARE GUIDELINES NON-METASTATIC DISEASE

Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report?

Pre-operative assessment of patients for cytoreduction and HIPEC

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES

11/21/13 CEA: 1.7 WNL

Manchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases

SEER EOD AND SUMMARY STAGE ABSTRACTORS TRAINING

This is the portion of the intestine which lies between the small intestine and the outlet (Anus).

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

Colorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015

Neoplastic Colon Polyps. Joyce Au SUNY Downstate Grand Rounds, October 18, 2012

Seventh Edition Staging 2017 Colorectum. Overview. This webinar is sponsored by. the Centers for Disease Control and Prevention.

Imaging in gastric cancer

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition

Rectal Cancer. About the Colon and Rectum. Symptoms. Colorectal Cancer Screening

Navigators Lead the Way

Billing Guideline. Subject: Colorectal Cancer Screening Exams (Invasive Procedures) Effective Date: 1/1/14 Last revision effective 4/16

Physician Follow-Up and Guideline Adherence in Post- Treatment Surveillance of Colorectal Cancer

Listed below are some of the words that you might come across concerning diseases and conditions of the bowels.

Overview. Collecting Cancer Data: Colon 11/5/2009. Collecting Cancer Data: NAACCR Webinar Series 1. Agenda NAACCR WEBINAR SERIES

What is endometrial cancer?

RECTAL CANCER CLINICAL CASE PRESENTATION

Preoperative Data Colorectal Cancer Database

Colorectal Cancer Care

Guidelines for Laparoscopic Resection of Curable Colon and Rectal Cancer

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I

Interactive Staging Bee

Your Medical Details and Treatment Tracker. About You

Shore Medical Center Site-Specific Study: Colorectal Cancer 2013

Appendix A UPMC Health System Quality Improvement Projects vs. Research Studies Quality Improvement Review Screening Tool

HIPEC Controversies in the Indications and Application of Regional Chemotherapy for Peritoneal Surface Malignancies

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

Carcinoma of the Urinary Bladder Histopathology

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

Locally Advanced Colon Cancer. Feiran Lou MD. MS. Richmond University Medical Center Department of Surgery

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

Small Bowel and Colon Surgery

Handling & Grossing of Colo-rectal Specimens for Tumours. for Medical Officers in Pathology

Case Conference. Craig Morgenthal Department of Surgery Long Island College Hospital

BOWEL CANCER. Cancer information.

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14

Cancer Program Report 2014

Outcomes Report: Accountability Measures and Quality Improvements

Screening & Surveillance Guidelines

ADJUVANT CHEMOTHERAPY...

Melanoma Quality Reporting

Requirements for Abstracted Text

A superficial radiotherapy B single pass curettage C excision with 2 mm margins D excision with 5 mm margins E Mohs micrographic surgery.

Colon Cancer , The Patient Education Institute, Inc. oc Last reviewed: 05/17/2017 1

Colon and Rectum 5/1/14

Definition of Synoptic Reporting

Neoplasms of the Colon and of the Rectum

Carcinoembryonic Antigen

Pancreas (Exocrine) Protocol applies to all carcinomas of the exocrine pancreas.

BOWEL CANCER. Causes of bowel cancer

Department of Surgery, Aizu Central Hospital, Fukushima

Colorectal Cancer. Mark Chapman. MA MS FRCS EBSQ(coloproct) 21 st March 2018 Consultant Coloproctologist

Outcomes Report: Accountability Measures and Quality Improvements

Colorectal Cancer Screening

Mini J.Elnaggar M.D. Radiation Oncology Ochsner Medical Center 9/23/2016. Background

A: PARTICIPANT INFORMATION

UPDATE IN THE MANAGEMENT AND TREATMENT OF COLORECTAL CANCER. Edwin A. Empaynado, MD Advocare Colon and Rectal Surgical Specialists

Glossary of Terms Primary Urethral Cancer

A916: rectum: adenocarcinoma

Colorectal Cancer at the MemorialCare Todd Cancer Institute at Long Beach Memorial

COLORECTAL CANCER STAGING in 2010

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

Guidelines for Assigning Summary Stage 2000

CURRENT PRACTICE OF FOLLOW-UP MANAGEMENT AFTER POTENTIALLY CURATIVE RESECTION OF RECTAL CANCER

Joseph Misdraji, M.D. GI pathology Unit Massachusetts General Hospital

Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R

Attending Physician Statement- Special Conditions

Case Scenario 1. Discharge Summary

Index. Note: Page numbers of article titles are in boldface type.

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

CT PET SCANNING for GIT Malignancies A clinician s perspective

LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013

Colorectal Cancer Treatment

Alison Douglass Gillian Lieberman, MD. November. Colon Cancer. Alison Douglass, Harvard Medical School Year III Gillian Lieberman, MD

Komplette Mesokolische Exzision (CME) Ergebnisse und Ausblicke

Faster Cancer Treatment Indicators: Use cases

Colon, Rectum, and Appendix

Colon, Rectum, and Appendix. Presentation Outline. Overview Tumor Characteristics

Transcription:

OFCCR CLINICAL DIAGNOSIS AND TREATMENT FORM Name: _, OFCCR # _ OCGN # _ OCR Group # _ HIN# Sex: MALE FEMALE UNKNOWN Date of Birth: DD MMM YYYY BASELINE DIAGNOSIS & TREATMENT 1. Place of Diagnosis: Name City or Town MOH Code 2. Site of Cancer(s): Cancer Site Name 4-Digit ICD-9 Code 1. 2. 3. 4. 5. 3. Date of initial diagnosis of colorectal cancer (pls. use histological date i.e. Date of path report): DD MMM YYYY 4. Preoperative symptoms (please check all that apply): None, asymptomatic (detected by screening) Bleeding Constipation Diarrhea Pain Weight Loss Other Please Specify: 5. Method of colorectal cancer diagnosis: Colonoscopy Rigid sigmoidoscopy Flexible sigmoidoscopy Sigmoidoscopy NOS Barium enema Chest x-ray Chest CT scan Abdominal/Pelvic CT scan Ultrasound Other Please Specify: 1

6. Type of definitive surgery for colorectal cancer (SEER coding used) (please attach all pathology and operative reports for this colorectal cancer): None Local tumour destruction, i.e. laser, electrocautery Local surgical excision with specimen i.e. polypectomy, snare Segmental resection, not hemi-colectomy i.e. cecectomy, appendectomy, sigmoidectomy, partial resection of transverse colon and flexures, iliocolectomy, enterocolectomy, partial colectomy, NOS Low Anterior Hemi-colectomy, but not total. Right or left, must include a portion of transverse colon Abdominoperineal resection Total or subtotal colectomy, not rectum Colectomy NOS Segmental colectomy + other organs (*Please specify below) Hemi-colectomy + other organs (*Please specify below) Total or subtotal colectomy or + other organs (*Please specify below) Abdominoperineal resection + other organs (*Please specify below) Other Please Specify: *If Other Organs were removed: Spleen Gallbladder Appendix (not a part of colon resection) Stomach Pancreas Small intestine Liver Abdominal Wall, Retroperitoneum Adrenal Kidney Bladder Urethra Ovary Uterus Vagina Prostate Other Please Specify: 7. If no surgery was performed, reason: Patient Refusal Antecedent Death Medical Contraindication Other Please Specify: 8. (a) Did the Proband receive treatment prior to their first surgery?: No Yes Chemotherapy Radiation 2

8. (b) Summary of disease from pathology report only: pt pn pm 9. Nodal Summary: Number of Nodes Reported (Checked) Number of Nodes Positive (If pn >=1) 10. Pathological Stage of disease (from all information available): T N M 11. Stage of disease at initial diagnosis (from all information available) OLD METHOD GROUPING 6 TH EDITION METHOD Stage 0 Tis N0 M0 Stage 0 Stage 1 T1, T2 N0 M0 Stage 1 Stage 2 T3 N0 M0 Stage 2A T4 N0 M0 Stage 2B Stage 3 T1, T2 N1 M0 Stage 3A T3, T4 N1 M0 Stage 3B Any T N2 M0 Stage 3C Stage 4 Any T Any N M1 Stage 4 UNABLE TO STAGE 12. Other Pathology Identified: Yes Type: No Unknown Crohn s Disease Ulcerative colitis Diverticulosis/it is Perforation Other Please Specify: 13. Preoperative CEA (carcinoembryonic antigen): Yes ug/l No 14. Date of Blood Test for Preoperative CEA: DD MMM YYYY 15. Date of surgery: DD MMM YYYY 16. Primary surgery hospital: Name City or Town MOH Code 17. Operating Surgeon: 18. Operative findings, local (residual tumour) (please obtain information from the operative report and/or the discharge summary) Tumour not entirely resected Tumour entirely resected 3

19. Operative findings, Distant (pls. obtain info. from the operative rep. &/or the discharge summ.): No Metastatic Disease Metastatic Disease Found Type of Metastatic Disease Found: Metastatic Resection After Baseline Surgery? (if applicable) Unknown Ascites Mesenteric nodes, other than in mesentery of planned resection Liver Lung Omentum Abdominal wall Ovaries Bone Peritoneum Mesentery Other Please Specify: _ Not Entirely resected Entirely resected Date(d/m/y): Notes: 20. Margins: Negative Positive Unknown Proximal Distal Radial Other Please Specify: (CONCURRENT) PRIMARY DIAGNOSIS # Please see Ques.#2 to identify Site #. (Please complete a separate form for each primary diagnosis). 21. Grade of Primary: Well Moderately Poorly Undifferentiated Unknown Differentiated Differentiated Differentiated 22. Cell Type: Adenoca. NOS Mucinous Signet ring cell Other Please specify: 23. Vascular Invasion: Yes No 24. Lymphatic Invasion: Yes No 25. Perineural Invasion: Yes 4

No 26. Patient Enrolled in a clinical trial: Yes Please Specify: No 27. Oncologist(s): Not assessed 1. 3. 2. 4. 28. Chemotherapy given (If yes, pls. complete Treatment table below & attach all flow sheets): Yes Type No (Pls. go to #32) Unknown Adjuvant Palliative Pseudo- Adjuvant Height Weight B.S.A.. cm. kg. m2 CHEMOTHERAPY TREATMENT (For cyclic chemo., pls. report each cycle separately e.g. 1, 2, 3, 4) FOR BASELINE DIAGNOSIS First Course Only. Flow sheet attached Y/N: Cycle # Name Drug Dosage IV/PO Days Given Date Given Palliative Therapy Response Progression Stable Minor Partial 5 Progression Stable Minor Partial Progression Stable Minor Partial Progression Stable Minor Partial Progression Stable Minor Partial

_ Progression Stable Minor Partial 32. Radiation given (please attach all flow sheets, where available): Yes Type No Unknown Adjuvant Palliative CLINICAL FOLLOW-UP SINCE BASELINE DIAGNOSIS Progression Stable Minor Partial Progression Stable Minor Partial 33. New cancer event in the four years following the initial diagnosis: Yes Check off as many that apply and complete the corresponding section. None Locoregional Recurrence Distant Recurrence Other Non-Colorectal Primary Colorectal Primary Death Unknown 34. Patient Enrolled in a clinical trial since baseline: Yes Please Specify: No 6

FIRST LOCOREGIONAL RECURRENCE None (go to #43) If applicable, please attach copies of documentation (i.e. radiology reports, clinic notes, pathology reports, operative reports, etc.) with the date of first detection of site(s) of first locoregional recurrence(s). 35. Sites of involvement at time of first locoregional recurrence (please check off all that apply): Site First Diagnosed Day First Diagnosed Month First Diagnosed Year Anastomosis Mesentery Abdominal Wall (not incisional) Incisional Pelvis Other Please specify: 36. Surgery for locoregional recurrence: Yes Please specify: No 37. Treatment for locoregional recurrence: Yes No 38. Oncologist(s): Not assessed 1. 3. 2. 4. 39. Chemotherapy given (If yes, pls. complete Treatment table below & attach all flow sheets): Yes Type No Unknown Adjuvant Palliative Pseudo- Adjuvant Height Weight B.S.A.. cm. kg. m2 7

CHEMOTHERAPY TREATMENT (For cyclic chemo., pls. report each cycle separately e.g. 1, 2, 3, 4) FOR FIRST LOCOREGIONAL RECURRENCE First Course. Flow sheet attached Y/N: Cycle # Name Drug Dosage IV/PO Days Given Date Given Palliative Therapy Response Progression Stable Minor Partial Progression Stable Minor Partial Progression Stable Minor Partial Progression Stable Minor Partial Progression Stable Minor Partial Progression Stable Minor Partial Progression Stable Minor Partial Progression Stable Minor Partial 8

40. Radiation given (please attach all flow sheets, where available): Yes Type No Unknown Adjuvant Palliative 41. Other treatment given (please attach all documents): Yes No 42. Other Locoregional recurrence sites after the 1st site was identified Site Diagnosed Day Diagnosed Month Anastomosis Mesentery Abdominal Wall (not incisional) Incisional Pelvis Other Please specify: Diagnosed Year FIRST DISTANT RECURRENCE None (go to #51) If applicable, please attach copies of documentation (i.e. radiology reports, clinic notes, pathology reports, operative reports, etc.) with the date of first detection of site(s) of first distant recurrence(s). 43. Sites of involvement at time of first distant recurrence (please check off all that apply): Site First Diagnosed Day First Diagnosed Month First Diagnosed Year Liver Lung Bone Ascites Non-mesenteric lymph nodes (except supraclavicular) Please specify: Supraclavicular nodes Brain Skin, except incision Please specify: _ Adrenal gland Other Please specify: _ 44. Surgery for distant recurrence: Yes Please specify: No 9

45. Treatment for distant recurrence: Yes No 46. Oncologist(s): Not assessed 1. 3. 2. 4. 47. Chemotherapy given (If yes, pls. complete Treatment table below & attach all flow sheets): Yes Type No Unknown Adjuvant Palliative Pseudo- Adjuvant Height Weight B.S.A.. cm. kg. m2 CHEMOTHERAPY TREATMENT (For cyclic chemo., pls. report each cycle separately e.g. 1, 2, 3, 4) FOR FIRST DISTANT RECURRENCE First Course. Flow sheet attached Y/N: Cycle # Name Drug Dosage IV/PO Days Given Date Given Palliative Therapy Response Progression Stable Minor Partial 10 Progression Stable Minor Partial Progression Stable Minor Partial Progression Stable Minor Partial Progression Stable Minor Partial

_ Progression Stable Minor Partial 48. Radiation given (please attach all flow sheets, where available): Yes Type No Unknown Adjuvant Palliative 49. Other treatment given (please attach all documents): Yes No Progression Stable Minor Partial Progression Stable Minor Partial 50. Other Distant recurrence sites after the first site was identified Diagnosed Day Site Liver Lung Bone Ascites Non-mesenteric lymph nodes (except supraclavicular) Please specify: Supraclavicular nodes Brain Skin, except incision Please specify: _ Adrenal gland Other Please specify: _ Diagnosed Month Diagnosed Year OTHER NON-COLORECTAL PRIMARY(S) None (go to #55) 51. Hospital of Diagnosis: Name City or Town MOH Code 11

52. Sites of new Non-Colorectal Primary Cancer(s) since the initial diagnosis of CRC: Cancer Site 4-Digit ICD-9 Code 1. 2. 3. 4. 5. 53. Date(s) of diagnosis of new Non-Colorectal Primary Cancer(s) (please use histological date): Cancer Day Month Year 1. 2. 3. 4. 5. 54. Stage(s) of new Non-Colorectal Primary Cancer(s): Cancer Stage 0 Stage 1 Stage 2 Stage 3 Stage 4 Unknown 1. 2. 3. 4. 5. NEW COLORECTAL PRIMARY(S) None (go to #80) 55. Site of Cancer(s): Cancer Site Name 4-Digit Diag. Diag. Diag. Unknown ICD-9 Code Day Month Year 1. 2. 3. 4. 5. 56. Preoperative symptoms (please check all that apply): None, asymptomatic (detected by screening) Bleeding Constipation Diarrhea Pain Weight Loss Other Please Specify: 12

57. Method of colorectal cancer diagnosis (check all that apply): Colonoscopy Rigid sigmoidoscopy Flexible sigmoidoscopy Sigmoidoscopy NOS Barium enema Chest x-ray Chest CT scan Abdominal CT scan Ultrasound Other Please Specify: 58. Type of definitive surgery for colorectal cancer (SEER coding used) (please attach all pathology and operative reports for this colorectal cancer): None Local tumour destruction, i.e. laser, electrocautery Local surgical excision with specimen i.e. polypectomy, snare Segmental resection, not hemi-colectomy i.e. cecectomy, appendectomy, sigmoidectomy, partial resection of transverse colon and flexures, iliocolectomy, enterocolectomy, partial colectomy, NOS Low Anterior Hemi-colectomy, but not total. Right or left, must include a portion of transverse colon Abdominoperineal resection Total or subtotal colectomy, not rectum Colectomy NOS Segmental colectomy + other organs (*Please specify below) Hemi-colectomy + other organs (*Please specify below) Total or subtotal colectomy or + other organs (*Please specify below) Abdominoperineal resection + other organs (*Please specify below) Other Please Specify: *If Other Organs were removed: Spleen Gallbladder Appendix (not a part of colon resection) Stomach Pancreas Small intestine Liver Abdominal wall, Retroperitoneum Adrenal Kidney Bladder Urethra Ovary Uterus Vagina Prostate Other Please Specify: 13

59. If no surgery was performed, reason: Patient Refusal Antecedent Death Medical Contraindication Other Please Specify: 60. (a) Did the Proband receive treatment prior to their first surgery: No Yes Chemotherapy Radiation 60. (b) Summary of disease from pathology report only: pt pn pm 61. Nodal Summary: Number of Nodes Reported (Checked) Number of Nodes Positive (If pn >=1) 62. Pathological Stage of disease (from all information available): T N M 63. Stage of disease at initial diagnosis (from all information available) OLD METHOD GROUPING 6 TH EDITION METHOD Stage 0 Tis N0 M0 Stage 0 Stage 1 T1, T2 N0 M0 Stage 1 Stage 2 T3 N0 M0 Stage 2A T4 N0 M0 Stage 2B Stage 3 T1, T2 N0 M0 Stage 3A T3, T4 N1 M0 Stage 3B Any T N2 M0 Stage 3C Stage 4 Any T Any N M1 Stage 4 UNABLE TO STAGE 64. Other Pathology Identified: Yes Type: No Unknown Crohn s Disease Ulcerative colitis Diverticulosis/it is Perforation Other Please Specify: 65. Preoperative CEA (carcinoembryonic antigen): Yes ug/l No 66. Date of Blood Test for Preoperative CEA: DD MMM YYYY 14

67. Date of surgery: DD MMM YYYY 68. Primary surgery hospital: Name City or Town MOH Code 69. Operating Surgeon: 70. Operative findings, local (residual tumour) (please obtain information from the operative report and/or the discharge summary) Tumour not entirely resected Tumour entirely resected 71. Operative findings, Distant (pls. obtain info. from the operative rep. &/or the discharge summ.): No Metastatic Metastatic Type of Metastatic Disease Found: Unknown Disease Disease Found Ascites Mesenteric nodes, other than in mesentery of planned resection Liver Lung Omentum Abdominal wall Ovaries Bone Peritoneum Mesentery Other Please Specify: _ 72. Margins: Negative Positive Unknown Proximal Distal Radial Other Please Specify: 15

(CONCURRENT) PRIMARY DIAGNOSIS # Please see Ques.#55 to identify Site #. (Please complete a separate form for each primary diagnosis). 73. Grade of Primary: Well Moderately Poorly Undifferentiated Unknown Differentiated Differentiated Differentiated 74. Cell Type: Adenoca. NOS Mucinous Signet ring cell Other Please specify: 75. Vascular Invasion: Yes No 76. Lymphatic Invasion: Yes No 77. Perineural Invasion: Yes No 16

78. Oncologist(s): Not assessed 1. 3. 2. 4. 79. Chemotherapy given (If yes, pls. complete Treatment table below & attach all flow sheets): Yes Type No Unknown Adjuvant Palliative Height Weight B.S.A.. cm. kg. m2 CHEMOTHERAPY TREATMENT (For cyclic chemo., pls. report each cycle separately e.g. 1, 2, 3, 4) FOR NEW CRC PRIMARY First Course Flow sheet attached Y/N: Cycle # Name Drug Dosage IV/PO Days Given Date Given Palliative Therapy Response Progression Stable Minor Partial 17 Progression Stable Minor Partial Progression Stable Minor Partial Progression Stable Minor Partial Progression Stable Minor Partial Progression Stable Minor Partial

_ Progression Stable Minor Partial 79. Radiation given (please attach all flow sheets, where available): Yes Type No Unknown Adjuvant Palliative DEATH 80. Date of Death: DD MMM YYYY Progression Stable Minor Partial 81. Cause of Death (please attach copy of death certificate if available): Colorectal cancer Other, No colorectal present Please specify: Other, colorectal present Please specify: 82. Autopsy performed (please attach copy of report if available): Yes No 83. Location of Death: Hospital Please specify: Home Hospice Please specify: Other Please specify: DATE OF FINAL CHART NOTE: PATIENT HAS BEEN REFERRED TO THE CARE OF: DR. ADDITIONAL FOLLOW-UP REQUIRED (Y/N): Date form Completed: (dd/mmm/yyyy) Abstractor s Initials: 18

ADDITIONAL NOTES: 19